Proposed Collection; 60-Day Comment Request; Next Series of Tobacco Use Supplements to the Current Population Survey, 3598-3599 [2014-01230]
Download as PDF
3598
Federal Register / Vol. 79, No. 14 / Wednesday, January 22, 2014 / Notices
agencies, and other entities participating
in the voluntary paternity establishment
program.
Respondents: State and Tribal IV–D
agencies, hospitals, birth record
agencies, and other entities participating
in the voluntary paternity establishment
program.
ANNUAL BURDEN ESTIMATES
Instrument
Number of
respondents
Number of
responses per
respondent
Average
burden hours
per response
Total burden
hours
None ................................................................................................................
1,113,719
1
0.17
189,332.23
Estimated Total Annual Burden
Hours: 189,332.23.
OMB Comment: OMB is required to
make a decision concerning the
collection of information between 30
and 60 days after publication of this
document in the Federal Register.
Therefore, a comment is best assured of
having its full effect if OMB receives it
within 30 days of publication. Written
comments and recommendations for the
proposed information collection should
be sent directly to the following:
Office of Management and Budget
Paperwork Reduction Project
Email: OIRA_SUBMISSION@
OMB.EOP.GOV
Attn: Desk Officer for the
Administration for Children and
Families
Robert Sargis,
Reports Clearance Officer.
[FR Doc. 2014–01097 Filed 1–21–14; 8:45 am]
BILLING CODE 4184–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Proposed Collection; 60-Day Comment
Request; Next Series of Tobacco Use
Supplements to the Current Population
Survey
In compliance with the
requirement of Section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995,
for opportunity for public comment on
proposed data collection projects, the
National Cancer Institute (NCI),
National Institutes of Health (NIH), will
publish periodic summaries of proposed
projects to be submitted to the Office of
Management and Budget (OMB) for
review and approval.
Written comments and/or suggestions
from the public and affected agencies
are invited on one or more of the
following points: (1) Whether the
proposed collection of information is
necessary for the proper performance of
emcdonald on DSK67QTVN1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
16:00 Jan 21, 2014
Jkt 232001
the function of the agency, including
whether the information will have
practical utility; (2) The accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used; (3)
Ways to enhance the quality, utility, and
clarity of the information to be
collected; and (4) Ways to minimize the
burden of the collection of information
on those who are to respond, including
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology.
To Submit Comments and for Further
Information: To obtain a copy of the
data collection plans and instruments,
submit comments in writing, or request
more information on the proposed
project, contact: Anne Hartman, Health
Statistician, Risk Factor Monitoring and
Methods Branch, National Cancer
Institute, NIH, MSC 9762, 9609 Medical
Center Drive, Bethesda, MD or call nontoll-free number 240–276–6704 or Email
your request, including your address to:
hartmana@mail.nih.gov. Formal
requests for additional plans and
instruments must be requested in
writing.
Comment Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 60 days of the date of
this publication.
Proposed Collection: Next Series of
Tobacco Use Supplements to the
Current Population Survey (TUS–CPS),
0925–0368, Expiration Date 03/31/2013,
Reinstatement with Change, National
Cancer Institute (NCI), National
Institutes of Health (NIH).
Need and Use of Information
Collection: The 2014–15 Tobacco Use
Supplement-Current Population Survey
(TUS–CPS) will be conducted by the
Census Bureau and is co-sponsored by
the National Cancer Institute (NCI) and
the Food and Drug Administration
(FDA). Fielded since 1992, most
DATES:
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
recently in 2010–11, this survey is part
of a continuing series of surveys (OMB
No. 0925–0368) sponsored by NCI that
has been administered triennially as
part of the Census Bureau’s and the
Bureau of Labor Statistics’ CPS. For the
TUS–CPS, data will be collected from
the U.S. civilian non-institutionalized
population on smoking, other tobacco
use, including switching, flavors,
dependence, cessation attempts, and
policy and social norms. The TUS–CPS
has been a key source of national, state,
some local-level, and health disparity
data on these topics in U.S. households
because it uses a large, nationally
representative sample. The 2014–15
TUS–CPS is designed to meet both
NCI’s and FDA’s goals. The NCI and
FDA are co-sponsoring the 2014–15
TUS–CPS through parallel, but separate
interagency agreements with the Census
Bureau. The NCI is particularly focused
on policy information such as home and
workplace smoking policies, cigarette
price, and impact of these on
subsequent purchase and use behavior;
and changes in smoking norms and
attitudes. The FDA aims to support
research to aid the development and
evaluation of tobacco product
regulations. The research findings
generated from this program are
expected to provide data to inform FDA
regulation of the manufacture,
distribution, and marketing of tobacco
products to protect public health. A
unique feature is the ability to link other
social and economic Census Bureau and
Bureau of Labor Statistics data, other
sponsor-supported supplement data,
and the National Longitudinal Mortality
Study cancer incidence and causespecific mortality data to the TUS–CPS
data. Data will be collected in July 2014,
January 2015, and May 2015 from about
255,000 respondents.
OMB approval is requested for 2
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
12,750.
E:\FR\FM\22JAN1.SGM
22JAN1
3599
Federal Register / Vol. 79, No. 14 / Wednesday, January 22, 2014 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondent
Number of
respondents
Responses
per respondent
Average burden
per response
(in hour)
Annual burden
hours
Individuals ................................................................................
127,500
1
6/60
12,750
Dated: January 15, 2014.
Vivian Horovitch-Kelley,
NCI Project Clearance Liaison, National
Institutes of Health.
[FR Doc. 2014–01230 Filed 1–21–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
emcdonald on DSK67QTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Population Sciences
and Epidemiology Integrated Review Group;
Infectious Diseases, Reproductive Health,
Asthma and Pulmonary Conditions Study
Section.
Date: February 12–13, 2014.
Time: 8:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Dupont Circle Hotel, 1500 New
Hampshire Ave. NW., Washington, DC
20036.
Contact Person: Lisa Steele, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3139,
MSC 7770, Bethesda, MD 20892, (301) 257–
2638, steeleln@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Chronic
Dysfunction and Integrative
Neurodegeneration Study Section.
Date: February 18, 2014.
Time: 11:00 a.m. to 11:30 a.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW.,
Washington, DC 20015.
VerDate Mar<15>2010
16:00 Jan 21, 2014
Jkt 232001
Contact Person: Samuel C Edwards, Ph.D.,
IRG CHIEF, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 5210, MSC 7846, Bethesda, MD
20892, (301) 435–1246, edwardss@
csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
conflict: Alcohol and Drugs.
Date: February 19–20, 2014.
Time: 8:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Michael Selmanoff, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5164,
MSC 7844, Bethesda, MD 20892, 301–435–
1119, selmanom@csr.nih.gov.
Name of Committee: Genes, Genomes, and
Genetics Integrated Review Group;
Genomics, Computational Biology and
Technology Study Section.
Date: February 19–20, 2014.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Agenda: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Barbara J Thomas, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2218,
MSC 7890, Bethesda, MD 20892, 301–435–
0603, bthomas@csr.nih.gov.
Name of Committee: Bioengineering
Sciences & Technologies Integrated Review
Group; Instrumentation and Systems
Development Study Section.
Date: February 19–20, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Kathryn Kalasinsky, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5158
MSC 7806, Bethesda, MD 20892, 301–402–
1074, kalasinskyks@mail.nih.gov.
Name of Committee: Cell Biology
Integrated Review Group; Intercellular
Interactions Study Section.
Date: February 19, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hotel Palomar, 2121 P Street NW.,
Washington, DC 20037.
Contact Person: Wallace Ip, Ph.D.,
Scientific Review Officer, Center for
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5128,
MSC 7840, Bethesda, MD 20892, 301–435–
1191, ipws@mail.nih.gov.
Name of Committee: Biological Chemistry
and Macromolecular Biophysics Integrated
Review Group; Synthetic and Biological
Chemistry B Study Section.
Date: February 19–20, 2014.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Serrano Hotel, 405 Taylor Street,
San Francisco, CA 94102.
Contact Person: Kathryn M Koeller, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4166,
MSC 7806, Bethesda, MD 20892, 301–435–
2681, koellerk@csr.nih.gov.
Name of Committee: Surgical Sciences,
Biomedical Imaging and Bioengineering
Integrated Review Group; Surgery,
Anesthesiology and Trauma Study Section.
Date: February 19–20, 2014.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Hotel and Executive Meeting
Center, 1750 Rockville Pike, Rockville, MD
20852.
Contact Person: Weihua Luo, MD, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5114,
MSC 7854, Bethesda, MD 20892, (301) 435–
1170, luow@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: January 15, 2014.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–01119 Filed 1–21–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Mental Health;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
E:\FR\FM\22JAN1.SGM
22JAN1
Agencies
[Federal Register Volume 79, Number 14 (Wednesday, January 22, 2014)]
[Notices]
[Pages 3598-3599]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-01230]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Proposed Collection; 60-Day Comment Request; Next Series of
Tobacco Use Supplements to the Current Population Survey
SUMMARY: In compliance with the requirement of Section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995, for opportunity for public comment
on proposed data collection projects, the National Cancer Institute
(NCI), National Institutes of Health (NIH), will publish periodic
summaries of proposed projects to be submitted to the Office of
Management and Budget (OMB) for review and approval.
Written comments and/or suggestions from the public and affected
agencies are invited on one or more of the following points: (1)
Whether the proposed collection of information is necessary for the
proper performance of the function of the agency, including whether the
information will have practical utility; (2) The accuracy of the
agency's estimate of the burden of the proposed collection of
information, including the validity of the methodology and assumptions
used; (3) Ways to enhance the quality, utility, and clarity of the
information to be collected; and (4) Ways to minimize the burden of the
collection of information on those who are to respond, including the
use of appropriate automated, electronic, mechanical, or other
technological collection techniques or other forms of information
technology.
To Submit Comments and for Further Information: To obtain a copy of
the data collection plans and instruments, submit comments in writing,
or request more information on the proposed project, contact: Anne
Hartman, Health Statistician, Risk Factor Monitoring and Methods
Branch, National Cancer Institute, NIH, MSC 9762, 9609 Medical Center
Drive, Bethesda, MD or call non-toll-free number 240-276-6704 or Email
your request, including your address to: hartmana@mail.nih.gov. Formal
requests for additional plans and instruments must be requested in
writing.
DATES: Comment Due Date: Comments regarding this information collection
are best assured of having their full effect if received within 60 days
of the date of this publication.
Proposed Collection: Next Series of Tobacco Use Supplements to the
Current Population Survey (TUS-CPS), 0925-0368, Expiration Date 03/31/
2013, Reinstatement with Change, National Cancer Institute (NCI),
National Institutes of Health (NIH).
Need and Use of Information Collection: The 2014-15 Tobacco Use
Supplement-Current Population Survey (TUS-CPS) will be conducted by the
Census Bureau and is co-sponsored by the National Cancer Institute
(NCI) and the Food and Drug Administration (FDA). Fielded since 1992,
most recently in 2010-11, this survey is part of a continuing series of
surveys (OMB No. 0925-0368) sponsored by NCI that has been administered
triennially as part of the Census Bureau's and the Bureau of Labor
Statistics' CPS. For the TUS-CPS, data will be collected from the U.S.
civilian non-institutionalized population on smoking, other tobacco
use, including switching, flavors, dependence, cessation attempts, and
policy and social norms. The TUS-CPS has been a key source of national,
state, some local-level, and health disparity data on these topics in
U.S. households because it uses a large, nationally representative
sample. The 2014-15 TUS-CPS is designed to meet both NCI's and FDA's
goals. The NCI and FDA are co-sponsoring the 2014-15 TUS-CPS through
parallel, but separate interagency agreements with the Census Bureau.
The NCI is particularly focused on policy information such as home and
workplace smoking policies, cigarette price, and impact of these on
subsequent purchase and use behavior; and changes in smoking norms and
attitudes. The FDA aims to support research to aid the development and
evaluation of tobacco product regulations. The research findings
generated from this program are expected to provide data to inform FDA
regulation of the manufacture, distribution, and marketing of tobacco
products to protect public health. A unique feature is the ability to
link other social and economic Census Bureau and Bureau of Labor
Statistics data, other sponsor-supported supplement data, and the
National Longitudinal Mortality Study cancer incidence and cause-
specific mortality data to the TUS-CPS data. Data will be collected in
July 2014, January 2015, and May 2015 from about 255,000 respondents.
OMB approval is requested for 2 years. There are no costs to
respondents other than their time. The total estimated annualized
burden hours are 12,750.
[[Page 3599]]
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Responses per Average burden per Annual burden
Type of respondent respondents respondent response (in hour) hours
----------------------------------------------------------------------------------------------------------------
Individuals..................... 127,500 1 6/60 12,750
----------------------------------------------------------------------------------------------------------------
Dated: January 15, 2014.
Vivian Horovitch-Kelley,
NCI Project Clearance Liaison, National Institutes of Health.
[FR Doc. 2014-01230 Filed 1-21-14; 8:45 am]
BILLING CODE 4140-01-P